Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease

Daniel E Weiner1, Sayed Tabatabai, Hocine Tighiouart

  • 1Division of Nephrology, Department of Internal Medicine, Tufts-New England Medical Center, Boston, MA 02111, USA. dweiner@tufts-nemc.org

Insights

Chronic kidney disease (CKD) and cardiovascular disease (CVD) are independent risk factors for adverse outcomes. While having both conditions significantly increases risk, they do not appear to act synergistically.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Chronic kidney disease (CKD) is a known risk factor for cardiovascular disease (CVD).
  • A potential bidirectional relationship exists, where CVD may also exacerbate CKD, forming a detrimental cycle.
  • This study investigates the combined impact of CKD and CVD on cardiovascular and mortality risks.

Purpose of the Study:

  • To determine if CKD and CVD have an additive or synergistic effect on future cardiovascular events and mortality.
  • To analyze the independent and combined risks associated with CKD and CVD.
  • To evaluate the interaction between CKD and CVD in a large, community-based cohort.

Main Methods:

  • Pooled data from four large community-based studies (Atherosclerosis Risk in Communities, Framingham Heart, Framingham Offspring, Cardiovascular Health Study).
  • CKD defined by estimated glomerular filtration rate < 60 mL/min/1.73 m(2).
  • Baseline CVD included myocardial infarction, angina, stroke, heart failure, and revascularization. Cox regression models were used to assess outcomes and test for interactions.

Main Results:

  • The study included 26,147 individuals with a 10-year follow-up.
  • Both CKD (HR 1.26) and CVD (HR 1.83) were independently associated with increased risk of the primary composite outcome (cardiac events, stroke, death).
  • The interaction between CKD and CVD was not statistically significant (HR 0.98), suggesting no synergistic effect.

Conclusions:

  • CKD and CVD are significant independent risk factors for adverse cardiovascular and mortality outcomes in the general population.
  • Individuals with both CKD and CVD face extremely high risks.
  • Despite the high-risk profile, CKD and CVD do not appear to exert a synergistic effect on these outcomes.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...